AlphaStocks
4.4
Weak

Progyny, Inc. (PGNY)

Health Care / Health Care Services

S&P SmallCap 600

$16.85

Below average on several measures. Research carefully.

Weak

Score based on 4 of 5 models — moderate confidence

#750out of 1127 in Health Care

Is Progyny, Inc. a Good Investment in 2026?

Progyny, Inc. (PGNY) scores 4.4 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Lynch model rates Progyny, Inc. as Strong (PEG 0.9 · Fast Grower). However, the Graham model rates it Caution — 59% above fair value. Progyny, Inc. currently trades above its estimated fair value of $14, suggesting limited upside at current prices. Progyny, Inc. ranks #750 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E25.9ROE8.5Market Cap1.5T

Estimated Fair Value

$14.2418% above

Trading slightly above estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

5/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

59% above fair value

Lynch

Strong

PEG 0.9 · Fast Grower

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Progyny, Inc. (PGNY) a good investment?
Based on AlphaStocks' composite analysis, Progyny, Inc. (PGNY) scores 4.4 out of 10, earning a Weak rating. This score is below average, suggesting caution. Trading slightly above estimated fair value.
What is Progyny, Inc.'s Piotroski F-Score?
Progyny, Inc.'s Piotroski F-Score status is Attractive. The raw score is 5/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is PGNY overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $14, PGNY appears overvalued. The stock currently trades 18% above its estimated fair value. Trading slightly above estimated fair value.
How does PGNY compare to other Health Care stocks?
Progyny, Inc. ranks #750 out of 1127 stocks in the Health Care sector, placing it in the top 67% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about PGNY?
AlphaStocks evaluates PGNY using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Caution; Lynch: Strong. These models are combined into a single composite score of 4.4/10.

Similar Stocks

PARRFTIAZN

Compare PGNY with

PGNY vs PARRPGNY vs FTIPGNY vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer